# OTOR

## Overview
OTOR is a gene that encodes the protein otoraplin, which is a member of the melanoma-inhibiting activity (MIA) family. Otoraplin is primarily expressed in the cochlea and is believed to play a crucial role in the survival and maintenance of hair cells and supporting cells in the inner ear, contributing to extracellular matrix organization and structural integrity of ear tissues (Wang2019OTOR). As a protein with SH3 domains, otoraplin is involved in extracellular processes and shares structural similarities with other MIA family proteins, suggesting its participation in cartilage development and maintenance (Mehrabipour2023A). Beyond its physiological roles, OTOR has been implicated in pathological conditions such as breast carcinoma, where its overexpression is associated with increased tumorigenicity and poor prognosis (Wang2019OTOR). Despite its recognized importance, the precise mechanisms and interaction networks of otoraplin remain subjects of ongoing research.

## Function
OTOR, also known as otoraplin, is primarily expressed in the cochlea and is thought to play a significant role in the survival and maintenance of hair cells and supporting cells in the inner ear. This protein is involved in cellular processes related to extracellular matrix organization, which is crucial for maintaining the structural integrity of ear tissues (Wang2019OTOR). OTOR is part of the MIA gene family, which includes proteins known for their roles in cell adhesion and cartilage development. The co-expression of OTOR with Col2A1, a marker gene involved in cell-cell contacts and adhesion, suggests its involvement in maintaining the structural framework of cartilaginous tissues, which are analogous to certain mammalian ear structures (Wang2019OTOR).

In the context of breast carcinoma, OTOR has been shown to be overexpressed in cancerous tissues compared to normal tissues, indicating a potential role in tumorigenesis. Its overexpression is associated with increased cell proliferation, migration, and invasion, possibly through the MEK-ERK signaling pathway, which is known to be involved in cancer progression (Wang2019OTOR). However, the precise mechanisms of OTOR's function in healthy human cells remain largely unexplored.

## Clinical Significance
The OTOR gene, also known as otoraplin, has been implicated in various clinical conditions due to its altered expression and potential mutations. In breast carcinoma, OTOR expression is significantly elevated in cancerous tissues compared to normal breast tissues. This overexpression is associated with increased tumorigenicity and poorer prognosis, correlating with clinicopathological features such as pathologic stage and primary lesion size. High OTOR expression is linked to shorter overall survival in breast cancer patients, suggesting its role as a prognostic marker. Functional assays have shown that silencing OTOR expression reduces breast cancer cell proliferation, migration, and invasion, indicating its involvement in these processes through the MEK-ERK signaling pathway (Wang2019OTOR).

In the context of hearing loss, the OTOR gene has been studied for its potential pathogenic variants. Although specific clinical significance in hearing disorders is not fully established, the gene was included in targeted next-generation sequencing panels for hearing impairment studies. Some variants in OTOR met criteria for potential pathogenicity, but further research is needed to confirm their clinical impact (Vona2014Targeted). The gene's role in cartilage development and maintenance suggests possible implications in cartilage-related conditions when dysregulated.

## Interactions
OTOR, or otoraplin, is part of the melanoma-inhibiting activity (MIA) family, which includes proteins with SH3 domains involved in extracellular processes. Although specific interactions of OTOR with other proteins or nucleic acids are not extensively documented, it shares structural similarities with other MIA family proteins, suggesting potential roles in extracellular matrix interactions (Mehrabipour2023A). 

OTOR has been shown to interact with a class II PPII helix peptide, as evidenced by chemical shift perturbations observed in NMR spectroscopy studies. This interaction is primarily driven by electrostatic forces at the disulfide and distal loop of OTOR, which is opposite to the classical SH3 domain interaction site (Arnolds2023Characterization). The dissociation constant for this interaction was determined to be 9.9 ± 2.9 µM, indicating a moderate binding affinity (Arnolds2023Characterization).

While OTOR's specific interaction partners remain largely unidentified, its structural characteristics and family association suggest it may participate in similar extracellular matrix processes as MIA, potentially influencing cartilage development and maintenance (Mehrabipour2023A). Further research is needed to elucidate the precise interaction network of OTOR.


## References


[1. (Arnolds2023Characterization) Oliver Arnolds and Raphael Stoll. Characterization of a fold in tango1 evolved from sh3 domains for the export of bulky cargos. Nature Communications, April 2023. URL: http://dx.doi.org/10.1038/s41467-023-37705-4, doi:10.1038/s41467-023-37705-4. This article has 7 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-37705-4)

[2. (Wang2019OTOR) Yu-Fei Wang and Jie Han. Otor in breast carcinoma as a potent prognostic predictor correlates with cell proliferation, migration, and invasiveness. Biochemistry and Cell Biology, 97(6):750–757, December 2019. URL: http://dx.doi.org/10.1139/bcb-2018-0305, doi:10.1139/bcb-2018-0305. This article has 3 citations.](https://doi.org/10.1139/bcb-2018-0305)

[3. (Vona2014Targeted) Barbara Vona, Tobias Müller, Indrajit Nanda, Cordula Neuner, Michaela A.H. Hofrichter, Jörg Schröder, Oliver Bartsch, Anne Läßig, Annerose Keilmann, Sebastian Schraven, Fabian Kraus, Wafaa Shehata-Dieler, and Thomas Haaf. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genetics in Medicine, 16(12):945–953, December 2014. URL: http://dx.doi.org/10.1038/gim.2014.65, doi:10.1038/gim.2014.65. This article has 80 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2014.65)

[4. (Mehrabipour2023A) Mehrnaz Mehrabipour, Neda S. Kazemein Jasemi, Radovan Dvorsky, and Mohammad R. Ahmadian. A systematic compilation of human sh3 domains: a versatile superfamily in cellular signaling. Cells, 12(16):2054, August 2023. URL: http://dx.doi.org/10.3390/cells12162054, doi:10.3390/cells12162054. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12162054)